BIO Share Price Performance
AU$0
-0.57 (-100.00%)
Price AU$0
Fair ValueAU$0.75
Share Pricen/a
Narrative Update • Jul 01
Biome Australia Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 22 Fair Values set on narratives written by author
BIO Community Narratives
AN
Fair Value
·Fair Value AU$0.75 66.0% undervalued intrinsic discount
Preventative Health Shift And Microbiome Therapies Will Support Strong Long-Term Business Upside
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
Preventative Health Shift And Microbiome Therapies Will Support Strong Long-Term Business Upside
Biome Australia is betting that more doctors and patients will turn to probiotics and other microbiome-based products as part of everyday health care, not just as supplements. The upside hinges on keeping its premium, clinically backed positioning while scaling into new overseas markets where quality options are still scarce.Read more
AN
AU$0.75
66.0% undervalued intrinsic discount
Fair Value
Revenue
32.61% p.a.
Profit Margin
20.01%
Future PE
20.57x
Price in 2029
AU$0.92
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
BIO: Higher Margin Outlook Will Drive Future Upside Potential
Fair Value: AU$0.75 66.0% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Biome Australia Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- 0.0042
- 61.17%
- 4.36%
- 24.8%
About BIO
- Founded
- 2018
- Employees
- n/a
- CEO
- WebsiteView website
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complementary medicines in Australia and internationally. The company provides probiotics as live biotherapeutic products under the Activated Probiotics brand, and nutraceutical and complementary medicines under the Activated Therapeutics brand. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.